# Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

> **NCT01060462** · — · COMPLETED · sponsor: **Janssen Korea, Ltd., Korea** · enrollment: 438 (actual)

## Conditions studied

- Hematological Malignancies
- Neutropenia
- Fever

## Interventions

- **DRUG:** Pts. w/ neutropenic fever associated w/ hematologic malignancy

## Key facts

- **NCT ID:** NCT01060462
- **Lead sponsor:** Janssen Korea, Ltd., Korea
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 438 (ACTUAL)
- **Last updated:** 2014-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060462, "Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01060462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*